As additionally highlighted by Jiang [9], earlier studies have used a mixed cohort of gliomas including WHO Grades II–IV or III–IV, and investigated either MGMT and IDH status alone or together [48,53,54]. This evidence concerns the gene IDH1 and central nervous system cancer.